2) In the conclusion of the abstract, please remove the word "reliably". I am not convinced that this study will be able to reliably determine the risk of unrecognized OSA in major noncardiac surgery. Relaibly is quite a strong statement. It will definitely provide the best evidence avaialble thus far.
3) In the first paragraph of the inroduction, instead of saying that frequent episodes of nocturnal apneas and hypopneas lead to oxyhemoglobin desaturation and myocardial ischemia, they should replace myocardial ischemia with surges in sympathetic activity. There is evidence that over the long run apneas and hypopneas lead to myocardial ischemia, however, there is no clear evidence that apneas and hypopneas cause myocardial ischemia during the night while they are occuring. We think apneas and hypopneas create an environment that is conducive to atherosclerosis leading to myocardial ischemia in the long run. So basically, the authors are referring to the pathophysiological substrates of OSA during sleep: intermittent hypoxemia and surges in sympathtic activity. Reference # 8 is also not appropriate because in the Gami study in the NEJM the authors talk about change in the timing of sudden cardiac death with OSA (instead of morning hours it happens more at night). They do not prove that it is ischemia related. In fact, it may be more related to arrhythmogenesis which may be due to sympathetic surges and increases in sympathetic tone (with reductions in vagal tone). The last sentence of the first paragraph also doesn't read well: "In addition, there is ongoing systemic inflammation, ...". Instead, the authors should consider rephrasing the sentence to the following: "In addition, OSA can increase systemic inflammation, ...".
4)
In the next paragraph of the intro, please replace hypoxia with hypoxemia. The sentence that states 50% of patients were undiagnosed is written in a way that is referring to the studies by Memtsoudis, Kaw, Lockhart and Mokhlesi. I think the authors need to write this sentence in a different way to avoid the impression of providing incorrect information. Perhaps they could state that it is difficult to interpret these findings since it is not clear what percentage of patients labeled as no-OSA had undiagnosed OSA. Then they can follow with the following sentence stating that other studies (Singh and Finkel as an example) have reported over 50% of patients with moderate to severe OSA being undiagnosed.
5) The authors should clearly state whether in their protocol those patients who undergo portable limited sleep testing in the hospital on the night before surgery are off supplemental oxygen. If they are on supplementaloxygen, then it is very difficult to interpret the findings. 6) In the second paragraph of "Overnight Polysomnography and pulse oximetry in the Methods", the authors should replace all PSG with portable limited sleep monitoring as stated above (including in the title of the paragraph). But more specifically, they should mention at the end of this paragraph that these devices are highly sensitive and specific in determining the AHI IN PATIENTS WITH MODERATE OR SEVERE OSA. These devices notoriously perform poorly in mild OSA. Also, the authors should refrain from referring to portbale limited sleep monitoring as a screening tool. It is not a screening tool. STOP-Bang or Berlin questionnaires are screening tools. These devices are used as diagnostic devices and diagnostic tools, not screening.
7) The authors should mention how many patients have been approached thus far and how many have consented to participate in the study. Is the rate of participation better at some centers vs. others?
8) The authors should discuss their limitations. For example, they can acknowledge that diagnosing OSA with portable limited sleep monitoring may underdiagnose mild OSA or erroneously classify them as no OSA.
9) The authors should mention how many subjects had device failure.
10) It remains unclear to this reviewer how the authors will control for postop CPAP or noninvasive PAP ventilation use. Are the clinicians allowed to use it postop and if so, are they planning to adjust for that in their analysis? 11) Please delete the sentence "A similar approach was adopted in the Wisconsin Sleep Cohort and SHHS." That is not exactly what WSCS and SHHS investigators did. There is no reason to make such statement and comparison. 12) In regards to statistical considerations, it remains unclear how the logistic regression models will be fitted. For example, the authors state that 4 independent variables will be introduced in the model: ethnicity, STOP-Bang risk score, presence or severity of OSA and the VISION risk model score. This raises several questions.
In the VISION study in JAMA, the authors adjusted for various covariates in Table 1 I also think it would be relevant for the authors to document the tidal volume received in the operating room given the new findings from the French Trial recently published in the NEJM. I think the question will come up and the authors will be well served to start monitoring it moving forward (if they have not been doing it already).
Why is hemorrhage included as part of vascular death?
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GENERAL COMMENTS
The question of post-operative risk of untreated obstructive sleep apnea in high cardiovascular risk patients during non-cardiac surgery is an important one.
The authors have designed a large prospective multicenter study to collect extensive peri-operative data that includes polysomnography, biomarkers, demographics, and cardiovascular outcomes. The methodology to capture complete and accurate data is rigorous. The outcomes are clearly defined.
The statistical analysis needs further development and description.
More description regarding how sample size was determined based on 6% expected event rate from the JAMA article would be helpful to include. It is not clear why AHI is used for logistic regression analysis of outcomes, but ODI is used for cox regression. Also, what is the justification for 10-second criteria for ODI? Some questions regarding methodology include how are differences in peri-operative care for high risk cardiovascular patients accounted for or standardized. Similarly, how are institutional differences in surgical care accounted for. For example, do all centers have similar hospitalization days for similar types of surgery? It is unclear the justification for considering only surgeries that have a minimum 3-day hospitalization standard. There is an unexplained disconnect why 26% of surgeries were minimally invasive yet required at least 3 days hospitalization. The authors should also discuss strengths and limitations, and attempt to address or provide rationale for these limitations. For example, AHI derived from total recording time versus sleep time will be inaccurate. Along the same lines, fixed recording times may lead to inaccurate AHI if patients are not sleeping during those hours.
VERSION 1 -AUTHOR RESPONSE
Reviewer: Dr Babak Mokhlesi, University of Chicago, United States
The POSA investigators describe their study design and preliminary demographic data. In general the manuscript is well written and the objectives clearly stated. This will be an important contribution to the field as there is almost no information about the relationship of OSA and postoperative outcomes from well-designed prospective studies. Their findings will have major public health implications since the global surgical volumes are mind boggling. I would like to point out to the authors a few minor concerns:
1) Please replace all references to polysomnography (PSG) in the manuscript with portable limited sleep monitoring.
Response: We have replaced "polysomnography (PSG)" throughout the manuscript with "type 3 portable sleep monitoring device" according to the practice parameters published by American Academy of Sleep Medicine, the American Thoracic Society, and the American College of Chest Physicians (Sleep 2003; 26:907-13) .
2) In the conclusion of the abstract, please remove the word "reliably". I am not convinced that this study will be able to reliably determine the risk of unrecognized OSA in major noncardiac surgery. Reliably is quite a strong statement. It will definitely provide the best evidence available thus far.
Response: We have removed the word "reliably" in the concluding remark of the abstract as suggested.
3) In the first paragraph of the introduction, instead of saying that frequent episodes of nocturnal apneas and hypopneas lead to oxyhemoglobin desaturation and myocardial ischemia, they should replace myocardial ischemia with surges in sympathetic activity. There is evidence that over the long run apneas and hypopneas lead to myocardial ischemia, however, there is no clear evidence that apneas and hypopneas cause myocardial ischemia during the night while they are occuring. We think apneas and hypopneas create an environment that is conducive to atherosclerosis leading to myocardial ischemia in the long run. So basically, the authors are referring to the pathophysiological substrates of OSA during sleep: intermittent hypoxemia and surges in sympathetic activity. Reference # 8 is also not appropriate because in the Gami study in the NEJM the authors talk about change in the timing of sudden cardiac death with OSA (instead of morning hours it happens more at night). They do not prove that it is ischemia related. In fact, it may be more related to arrhythmogenesis which may be due to sympathetic surges and increases in sympathetic tone (with reductions in vagal tone). The last sentence of the first paragraph also doesn't read well: "In addition, there is ongoing systemic inflammation, ...". Instead, the authors should consider rephrasing the sentence to the following: "In addition, OSA can increase systemic inflammation, ...".
Response: We have revised the paragraph (page 3, paragraph 1) according to Dr Mokhlesi's suggestion. We have replaced reference #8 with a recent study by the same investigators on OSA and sudden cardiac death (J Am Coll Cardiol 2013; 62:610-616) . This paper discussed the role of sympathetic activity and arrhythmia during sleep apnea.
We added the following to the text, page 3, paragraph 1: "… This is commonly attributed to the frequent episodes of nocturnal apnea and hypopnea that lead to oxyhemoglobin desaturation and surges of sympathetic activity. 5) The authors should clearly state whether in their protocol those patients who undergo portable limited sleep testing in the hospital on the night before surgery are off supplemental oxygen. If they are on supplemental oxygen, then it is very difficult to interpret the findings.
Response: We have explicitly stated that "All patients breathe room air during preoperative recording." (page 6, end of paragraph 1) 6) In the second paragraph of "Overnight Polysomnography and pulse oximetry in the Methods", the authors should replace all PSG with portable limited sleep monitoring as stated above (including in the title of the paragraph). But more specifically, they should mention at the end of this paragraph that these devices are highly sensitive and specific in determining the AHI IN PATIENTS WITH MODERATE OR SEVERE OSA. These devices notoriously perform poorly in mild OSA. Also, the authors should refrain from referring to portable limited sleep monitoring as a screening tool. It is not a screening tool. STOP-Bang or Berlin questionnaires are screening tools. These devices are used as diagnostic devices and diagnostic tools, not screening. 7) The authors should mention how many patients have been approached thus far and how many have consented to participate in the study. Is the rate of participation better at some centers vs. others?
Response: There was no difference in the rate of participation among centers. We have included patient flow in page 11, paragraph 2. "The POSA Study is currently enrolling patients from 8 centers in 6 countries. As of November 2013, we have screened 998 patients who fulfilled the POSA eligibility criteria. Among these patients, 294
were not enrolled to the study because 265 patients did not consent or their surgeons did not approve patient participation. In addition, 29 patients were excluded because ApneaLink was not available (n = 2) or preoperative recording was not successful (n = 27). Currently, 704 patients are included in the POSA study and over 650 patients have completed the 30-day follow-up."
Response: We have added the following paragraph to the text in page 10, paragraph 3: "Potential limitations of the POSA Study Given the resource constraints; it is impractical to perform standard in-laboratory attended polysmnography for all patients in the POSA Study. We have therefore resorted to use a type 3 portable sleep monitoring device. It is known that these devices may underestimate AHI values especially in patients with mild OSA.
[31] Therefore, these patients may be erroneously classified as non-OSA. Nevertheless, ApneaLink measurements appeared to correlate with standard polysmnography. At AHI value of 5, the sensitivity and specificity ranged between 85.4-100% and 50.0-100%, respectively. [21] [22] [23] [24] It should be noted that we do not measure electroencephalogram in our sleep monitoring, and hence we cannot track whether the patient is asleep during measurement. We therefore standardized recordings by processing data collected between 23:00 and 06:00 hours, even though the patients may be awake during the period."
Response: We have indicated the number of patients with device failure in page 11, paragraph 2, please refer to point 7 above.
10) It remains unclear to this reviewer how the authors will control for postop CPAP or noninvasive PAP ventilation use. Are the clinicians allowed to use it postop and if so, are they planning to adjust for that in their analysis?
Response: Patients with previous diagnosis of obstructive sleep apnea or any sleep-related breathing disorder were excluded from the POSA study (Table 1) . Therefore, none of the patients were planned to receive postoperative CPAP. In contrast, patients who require mechanical ventilation or CPAP after surgery are considered as meeting the secondary endpoint. We have clarified this endpoint in page 8, paragraph 3 as following: "Secondary endpoints include the following: (1) tracheal intubation and mechanical ventilation (including use of continuous positive airway pressure ventilation) after surgery; …" 11) Please delete the sentence "A similar approach was adopted in the Wisconsin Sleep Cohort and SHHS." That is not exactly what WSCS and SHHS investigators did. There is no reason to make such statement and comparison.
Response: We have removed this sentence as suggested.
12) In regards to statistical considerations, it remains unclear how the logistic regression models will be fitted. For example, the authors state that 4 independent variables will be introduced in the model: ethnicity, STOP-Bang risk score, presence or severity of OSA and the VISION risk model score. This raises several questions.
In the VISION study in JAMA, the authors adjusted for various covariates in Table 1 Table 3 of the JAMA paper (2012; 307:2295-304) and is described in more detail in another paper recently accepted for publication in Anesthesiology. The model does not incorporate gender, body mass index, other comorbidities, duration of surgery or type of anesthesia. But these factors were not associated with 30-day postoperative vascular events in the VISION Study. The fact that we can summarize the clinical predictors using the VISION risk model, we are able to reduce the sample size required substantially to determine the association between OSA and risk of postoperative vascular events.
Why do the authors want to enter the STOP-Bang score in the regression model if they have an AHI or OSA severity from the portable limited sleep monitoring. It doesn't make any sense, unless I am missing something or if they expect that not everyone will get diagnostic sleep testing with the ApneaLink.
Response: We have clarified our statistical approach in page 9, paragraph 2. In the first regression model, we plan to test whether OSA is associated with postoperative vascular events. The independent predictors are ethnicity, VISION risk model score and the presence of OSA (according to its severity, based on AHI values, with non-OSA as reference). In addition, we test whether clinical screening tool of OSA (e.g. STOP-Bang score) could also be used to predict postoperative vascular events. In this regression model, we replace AHI values with STOP-Bang score.
I also think it would be relevant for the authors to document the tidal volume received in the operating room given the new findings from the French Trial recently published in the NEJM. I think the question will come up and the authors will be well served to start monitoring it moving forward (if they have not been doing it already).
Response: Thanks you for the suggestion. Currently, we have not collected data on tidal volume, but we will be able to retrieve these data easily because they have been recorded electronically with our intraoperative data management system.
Response: We have removed this from the definition. However, in all deaths that was reported, there were associated myocardial ischemia as a consequence to hemorrhage and hypotension.
Reviewer: Dr Christine Won, Yale University
The statistical analysis needs further development and description. More description regarding how sample size was determined based on 6% expected event rate from the JAMA article would be helpful to include. It is not clear why AHI is used for logistic regression analysis of outcomes, but ODI is used for cox regression. Also, what is the justification for 10-second criteria for ODI? Some questions regarding methodology include how are differences in peri-operative care for high risk cardiovascular patients accounted for or standardized. Similarly, how are institutional differences in surgical care accounted for. For example, do all centers have similar hospitalization days for similar types of surgery? It is unclear the justification for considering only surgeries that have a minimum 3-day hospitalization standard. There is an unexplained disconnect why 26% of surgeries were minimally invasive yet required at least 3 days hospitalization. The authors should also discuss strengths and limitations, and attempt to address or provide rationale for these limitations. For example, AHI derived from total recording time versus sleep time will be inaccurate. Along the same lines, fixed recording times may lead to inaccurate AHI if patients are not sleeping during those hours.
Response: We calculate the sample size based on the data from the VISION study (JAMA 2012; 307:2295-304) . In this study 1,121 patients (7.4%) had elevated postoperative cardiac troponin values (eTable 2 of the JAMA paper). Given that a fraction of these patients did not have ischemic symptoms, ECG or imaging changes and therefore did not fulfill the universal definition of myocardial infarction, we calculate our sample size using a conservative estimate of 6%.
The purpose of correlating ODI with postoperative cardiac events is to determine the effect of nocturnal hypoxia during the first 3 nights after surgery in patients with and without OSA. We will not perform sleep monitoring during this period, therefore we are unable to use AHI in the Cox regression model.
We chose 10-second criteria and 4% desaturation for ODI because there was a good agreement between ODI and AHI in our previous publication (Anesth Analg 2012; 114:993-1000).
We do not attempt to standardized perioperative patient care so as to reflect common practice. We believe this will allow the findings to be more readily generalized. Currently, we do not detect significant difference in hospital stay among centers.
We aim to recruit patients undergoing major surgery that require a hospital stay of ≥ 3 nights, because majority of the vascular events occur during this period. Although a substantial proportion of surgery was considered as minimally invasive in the POSA Study, all of these procedures were major (e.g. laparoscopic radical cystectomy) and would require more than 3 days of recovery in the hospital.
We have described the limitations of the POSA study in the revised manuscript (page 10, paragraph 3).
